14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Mar 06, 2020 $4.33 $4.38 $4.11 $4.28 525 467
Mar 05, 2020 $4.69 $4.81 $4.42 $4.45 264 762
Mar 04, 2020 $4.80 $4.84 $4.61 $4.76 220 504
Mar 03, 2020 $4.89 $5.09 $4.58 $4.75 361 766
Mar 02, 2020 $4.77 $4.89 $4.52 $4.82 391 914
Feb 28, 2020 $4.39 $4.83 $4.35 $4.73 317 416
Feb 27, 2020 $4.80 $4.91 $4.42 $4.65 399 230
Feb 26, 2020 $4.82 $5.10 $4.80 $4.92 383 631
Feb 25, 2020 $5.09 $5.24 $4.82 $4.87 580 737
Feb 24, 2020 $5.28 $5.30 $5.01 $5.07 774 346
Feb 21, 2020 $5.67 $5.68 $5.30 $5.35 734 872
Feb 20, 2020 $5.70 $5.75 $5.45 $5.69 713 410
Feb 19, 2020 $5.74 $5.75 $5.30 $5.55 1 321 318
Feb 18, 2020 $5.28 $5.52 $5.25 $5.41 1 533 591
Feb 14, 2020 $5.05 $5.25 $5.05 $5.12 333 576
Feb 13, 2020 $4.91 $5.15 $4.85 $5.14 372 174
Feb 12, 2020 $5.19 $5.33 $4.84 $4.93 701 584
Feb 11, 2020 $5.07 $5.27 $5.02 $5.14 583 178
Feb 10, 2020 $5.14 $5.32 $5.00 $5.00 1 055 729
Feb 07, 2020 $5.25 $5.48 $4.99 $5.00 3 240 531
Feb 06, 2020 $6.38 $6.48 $5.69 $5.71 1 133 661
Feb 05, 2020 $6.49 $7.01 $6.48 $7.01 240 789
Feb 04, 2020 $6.14 $6.59 $6.07 $6.44 318 947
Feb 03, 2020 $6.27 $6.38 $5.89 $6.09 422 677
Jan 31, 2020 $6.30 $6.42 $6.25 $6.28 216 198
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT